Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV2 omicron sublineages
iScience Touret F, Giraud E, Bourret J, Donati F, Tran-Rajau J, Chiaravalli J, Lemoine F, Agou F, Simon-Lorière E, van der Werf S, de...
top of page
Mar 17, 2023
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential
Full title: Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants...
Feb 14, 2023
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Nat Commun. Planas D, Bruel T, Staropoli I, Guivel-Benhassine F, Porrot F, Maes P, Grzelak L, Prot M, Mougari S, Planchais C, Puech J,...
Mar 23, 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages in patients receiving monoclonal antibodies
Full title: Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies. Nat Med...
bottom of page